The efficacy of Alahmady ring implantation in the management of neovascular glaucoma
Alahmady H Alsmman, Gamal Radwan, Mohammed Elagouz, Usama Ali Mohammed The Department of Ophthalmology, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt Purpose: To evaluate the efficacy and safety of Alahmady ring implantation in the management of neovascular glaucoma.Methods: A total of...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/371c869cdf2242cfb9db88ca8a018073 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:371c869cdf2242cfb9db88ca8a018073 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:371c869cdf2242cfb9db88ca8a0180732021-12-02T00:30:10ZThe efficacy of Alahmady ring implantation in the management of neovascular glaucoma1177-5483https://doaj.org/article/371c869cdf2242cfb9db88ca8a0180732017-03-01T00:00:00Zhttps://www.dovepress.com/the-efficacy-of-alahmady-ring-implantation-in-the-management-of-neovas-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Alahmady H Alsmman, Gamal Radwan, Mohammed Elagouz, Usama Ali Mohammed The Department of Ophthalmology, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt Purpose: To evaluate the efficacy and safety of Alahmady ring implantation in the management of neovascular glaucoma.Methods: A total of 15 eyes of 15 patients with intractable neovascular glaucoma with intraocular pressure (IOP) ≥28 mmHg not responding to medical treatment were retrospectively analyzed. All patients had poor visual acuity and underwent Alahmady ring implantation. The ring was designed from fenestrated silicon tube used in lacrimal surgeries and was implanted subsclerally after passing it through the anterior chamber. Patients were followed up for at least 24 months. Success in this study was defined based on IOP ≥8 mmHg and <21 mmHg, with not more than 1 glaucoma drug, and improvement of patient symptoms and signs with maximum use of beta blocker as antiglaucoma drug.Results: A total of 15 eyes of 15 patients (9 males [60%] and 6 females [40%]) were analyzed in this study. The mean IOP before surgery was 38.6 mmHg (standard deviation [SD]: 6.98) and it was 14.05 mmHg (SD =7.57) after surgery. The follow-up range was 24–36 months. Success of silicon drainage device was defined as an IOP <21 mmHg on the last follow-up visit. Medications included only beta-blockers and topical steroids for those who were without severe complications or for those who were not in a condition to undergo a further glaucoma surgery.Conclusion: Alahmady ring implantation proves to be a good surgical option for neovascular glaucoma; however, a longer follow-up period is recommended. Keywords: refractory glaucoma, glaucoma device, failed trabeculectomyAlsmman AHRadwan GElagouz MMohammed UADove Medical PressarticleAlahmady ringglaucoma deviceneovascular glaucomaOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 541-548 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Alahmady ring glaucoma device neovascular glaucoma Ophthalmology RE1-994 |
spellingShingle |
Alahmady ring glaucoma device neovascular glaucoma Ophthalmology RE1-994 Alsmman AH Radwan G Elagouz M Mohammed UA The efficacy of Alahmady ring implantation in the management of neovascular glaucoma |
description |
Alahmady H Alsmman, Gamal Radwan, Mohammed Elagouz, Usama Ali Mohammed The Department of Ophthalmology, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt Purpose: To evaluate the efficacy and safety of Alahmady ring implantation in the management of neovascular glaucoma.Methods: A total of 15 eyes of 15 patients with intractable neovascular glaucoma with intraocular pressure (IOP) ≥28 mmHg not responding to medical treatment were retrospectively analyzed. All patients had poor visual acuity and underwent Alahmady ring implantation. The ring was designed from fenestrated silicon tube used in lacrimal surgeries and was implanted subsclerally after passing it through the anterior chamber. Patients were followed up for at least 24 months. Success in this study was defined based on IOP ≥8 mmHg and <21 mmHg, with not more than 1 glaucoma drug, and improvement of patient symptoms and signs with maximum use of beta blocker as antiglaucoma drug.Results: A total of 15 eyes of 15 patients (9 males [60%] and 6 females [40%]) were analyzed in this study. The mean IOP before surgery was 38.6 mmHg (standard deviation [SD]: 6.98) and it was 14.05 mmHg (SD =7.57) after surgery. The follow-up range was 24–36 months. Success of silicon drainage device was defined as an IOP <21 mmHg on the last follow-up visit. Medications included only beta-blockers and topical steroids for those who were without severe complications or for those who were not in a condition to undergo a further glaucoma surgery.Conclusion: Alahmady ring implantation proves to be a good surgical option for neovascular glaucoma; however, a longer follow-up period is recommended. Keywords: refractory glaucoma, glaucoma device, failed trabeculectomy |
format |
article |
author |
Alsmman AH Radwan G Elagouz M Mohammed UA |
author_facet |
Alsmman AH Radwan G Elagouz M Mohammed UA |
author_sort |
Alsmman AH |
title |
The efficacy of Alahmady ring implantation in the management of neovascular glaucoma |
title_short |
The efficacy of Alahmady ring implantation in the management of neovascular glaucoma |
title_full |
The efficacy of Alahmady ring implantation in the management of neovascular glaucoma |
title_fullStr |
The efficacy of Alahmady ring implantation in the management of neovascular glaucoma |
title_full_unstemmed |
The efficacy of Alahmady ring implantation in the management of neovascular glaucoma |
title_sort |
efficacy of alahmady ring implantation in the management of neovascular glaucoma |
publisher |
Dove Medical Press |
publishDate |
2017 |
url |
https://doaj.org/article/371c869cdf2242cfb9db88ca8a018073 |
work_keys_str_mv |
AT alsmmanah theefficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma AT radwang theefficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma AT elagouzm theefficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma AT mohammedua theefficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma AT alsmmanah efficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma AT radwang efficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma AT elagouzm efficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma AT mohammedua efficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma |
_version_ |
1718403668684832768 |